Compare Intiland Development Tbk. (DILD) vs Cipta Sarana Medika Tbk. (DKHH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Intiland Development Tbk. vs Cipta Sarana Medika Tbk. — how do they compare? Intiland Development Tbk. trades at Rp115 (market cap 1.2T, 13.27M 24h volume), while Cipta Sarana Medika Tbk. trades at Rp65 (market cap 160.67B, 13M 24h volume). The key difference: Intiland Development Tbk. is far larger — about 7.5× Cipta Sarana Medika Tbk.'s market cap, and Intiland Development Tbk. is more actively traded (13.27M versus 13M). Which is the better fit depends on your goals.
| DILD | DKHH | |
|---|---|---|
Market Cap | 1.2T | 160.67B |
Volume | 13.27M | 13M |
Lot | 132.7K | 130K |
Turnover | 1.52B | 832.52M |
Average Price | 114.29 | 64.04 |
Value | 1.52B | 832.52M |
Indicative Equilibrium Price | 116 | 63 |
Indicative Equilibrium Volume | 389.5K | 4.8K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Intiland Development Tbk.
PT Intiland Development Tbk formerly Dharmala Intiland, controlled by the Gondokusumo family, was established in 1983 as the property arm of the Dharmala Group. The company is basically a real estate developer with its principal asset being the 240-hectare Grande Family Estate in Surabaya.
Read more on DILD →About Cipta Sarana Medika Tbk.
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →
